1. 4CPS-002 Effectiveness and safety of monoclonal antibodies for migraine prevention after two and a half years of clinical experience. Issue 1 (23rd March 2023) Authors: Fresan, D; Yerro, A; Pastalle, A; Garcia, C; Calvo, M; Ortega, I; Lacalle, E; Juanbeltz, R; Idoate, AI; Sarobe, MT; Noceda, MM Journal: European journal of hospital pharmacy Issue: Volume 30:Issue 1(2023)supplement 1 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-045 Cost effectiveness analysis of meropenem dose optimisation in critical patients. (24th March 2020) Authors: Idoate, AI; Aldaz, A; Aquerreta, I; Ortega, A Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-058 Avoid simultaneus prescription between linezolid and voriconazole: pharmacokinetic study. (March 2019) Authors: Idoate, AI; Leache, L; Aldaz, A Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 4CPS-059 Effectiveness of meropenem treatment in critical patients: pharmacokinetic study. (March 2019) Authors: Idoate, AI; Aldaz, A Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PKP-027 Significant interactions in treatment of dravet syndrome. (14th February 2016) Authors: Idoate, AI; Aldaz, A; Parra, A; Sanchez-Carpintero, R Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗